Teva Recalls Terazosin Hydrochloride Capsules Due to Foreign Capsule Presence
Teva Pharmaceuticals USA is recalling specific lots of Terazosin Hydrochloride Capsules because a foreign capsule was found in one bottle.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a foreign object contamination that is a low-risk physical hazard without reported injuries or illnesses, fitting the criteria for a moderate severity score.
Plain-English summary
Teva Pharmaceuticals USA, Inc. is recalling 3,913 bottles of Terazosin Hydrochloride Capsules, 2 mg. The affected product is packaged in 100-count bottles (NDC 0093-4337-01) and 1000-count bottles (NDC 0093-4337-10). The specific lot number is N03029 with an expiration date of 03/14. The product was manufactured in India by Intas Pharmaceuticals Ltd. for Teva Pharmaceuticals USA.
The recall is being conducted due to the presence of a foreign capsule found in one bottle. The agency has classified this recall as Class II. The product was distributed nationwide.
Consumers should check their medication for the specific NDC numbers and lot number listed above. If the product matches the recalled description, they should stop using it and contact their pharmacist or healthcare provider for guidance on replacement or disposal.
The recalled product
- Product
- Terazosin Hydrochloride Capsules, 2 mg, packaged in a) 100-count bottles (NDC 0093-4337-01); and b) 1000-count bottles (NDC 0093-4337-10), Rx only, Manufactured in India By: Intas Pharmaceuticals Ltd., Ahmedabad, Gujarat, India - 382 210; Manufactured For: Teva Pharmaceuticals…
- Manufacturer
- Teva Pharmaceuticals USA, Inc.
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 3,913
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # N03029
- Exp 03/14
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Teva Pharmaceuticals USA, Inc.
See all →- SevereTeva Recalls Trazodone Hydrochloride Tablets Due to Foreign Material
FDA (Drugs) · 2026-09-09
- SevereOctreotide Acetate Injectable Suspension Recalled Due to Sterility Assurance
FDA (Drugs) · 2026-05-13
- ModerateClaravis isotretinoin 10 mg capsules recalled for out-of-specification impurity
FDA (Drugs) · 2026-04-29
- ModerateTeva clonidine 0.3 mg patches recalled over unapproved raw material use
FDA (Drugs) · 2026-04-15
- HighTeva isotretinoin 40 mg capsules recalled as superpotent and subpotent
FDA (Drugs) · 2026-04-15
Same hazard · foreign object
See all →- ModerateMezzetta Golden Greek Peperoncini Recalled for Potential Mouse Contamination
FDA (Food) · 2026-10-14
- SevereUnited and Good & Gather Light Brown Sugar Recalled for Wheat Contamination
FDA (Food) · 2026-09-30
- SevereBaxter Recalls Dextrose Injection Bags Due to Stainless Steel Particulate Matter
FDA (Drugs) · 2026-09-16
- ModerateBionpharma Recalls Doxylamine Succinate Tablets Due to Foreign Material Presence
FDA (Drugs) · 2026-09-09
- SevereUkrop's Bread Pudding Recalled for Metal Fragments
FDA (Food) · 2026-09-09
Similar recalls
- ModerateTeva Recalls Terazosin Hydrochloride Capsules Due to Labeling Error
FDA (Drugs) · 2013-08-14
- SevereTeva Recalls Trazodone Hydrochloride Tablets Due to Foreign Material
FDA (Drugs) · 2026-09-09
- ModerateTeva Recalls Indomethacin Capsules Due to Manufacturing Quality Deviations
FDA (Drugs) · 2014-05-21
- HighTrazodone tablets recalled over the presence of foreign tablets
FDA (Drugs) · 2026-02-11
- HighPrazosin capsules recalled over nitrosamine impurity above the acceptable intake limit
FDA (Drugs) · 2025-11-05
- SevereTeva Recalls Valacyclovir Tablets Due to Potential Foreign Tablet Fragments
FDA (Drugs) · 2014-02-12